Voloridge Investment Management
QNCX icon

Voloridge Investment Management’s Quince Therapeutics QNCX Stock Holding History

Voloridge Investment Management’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,130
Closed -$2.64M – 1601
2022
Q1 		$2.64M Sell
2,130
-101
-5% -$137K 0.02% 857
2021
Q4 		$5.63M Buy
2,231
+1,883
+541% +$11.5M 0.03% 680
2021
Q3 		$6.37M Buy
348
+182
+110% +$2.89M 0.04% 585
2021
Q2 		$1.76M Buy
+166
New +$1.39M 0.01% 1035
2021
Q1 		– Sell
-164
Closed -$910K – 1611
2020
Q4 		$910K Buy
+164
New +$1.45M 0.01% 995

Other funds holding QNCX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
PHAM
Pacific Heights Asset Management San Francisco, California $2.99B AUM 52.5% 1-Year Est. Return